Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
33.333 (89/267) |
7.28E-29 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
29.304 (80/273) |
5.49E-21 |
BR serine/threonine kinase 2 (BRSK2)
|
|
30.233 (78/258) |
1.15E-20 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
23.574 (62/263) |
1.60E-20 |
Serine/threonine-protein kinase 26 (STK26)
|
|
28.340 (70/247) |
1.01E-19 |
BR serine/threonine kinase 1 (BRSK1)
|
|
29.804 (76/255) |
1.08E-19 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
27.407 (74/270) |
2.57E-19 |
Serine/threonine-protein kinase 24 (STK24)
|
|
27.935 (69/247) |
3.38E-19 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
27.815 (84/302) |
3.96E-19 |
Oxidative stress responsive 1 (OXSR1)
|
|
29.818 (82/275) |
9.98E-19 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
29.204 (66/226) |
1.01E-18 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
29.646 (67/226) |
1.54E-18 |
Cyclin-dependent kinase 13 (CDK13)
|
|
28.571 (68/238) |
1.55E-18 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
28.319 (64/226) |
2.49E-18 |
Serine/threonine-protein kinase 25 (STK25)
|
|
28.287 (71/251) |
3.22E-18 |
Omphalocele kinase 1 (NUAK1)
|
|
27.381 (69/252) |
5.17E-18 |
Ste-20-related kinase (STK39)
|
|
31.507 (69/219) |
6.42E-18 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
26.515 (70/264) |
9.26E-18 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
31.304 (72/230) |
3.39E-17 |
Myosin light chain kinase 2 (MYLK2)
|
|
31.278 (71/227) |
3.56E-17 |
Polo-like kinase 2 (PLK2)
|
|
25.283 (67/265) |
3.74E-17 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.646 (67/226) |
3.89E-17 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
27.165 (69/254) |
3.90E-17 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
26.190 (66/252) |
4.29E-17 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
30.565 (92/301) |
5.42E-17 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
28.519 (77/270) |
1.20E-16 |
Polo-like kinase 4 (PLK4)
|
|
27.407 (74/270) |
1.44E-16 |
Cyclin-dependent kinase 12 (CDK12)
|
|
28.151 (67/238) |
2.02E-16 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
27.839 (76/273) |
2.09E-16 |
Unc-51 like kinase 3 (ULK3)
|
|
26.667 (68/255) |
2.48E-16 |
Cyclin-dependent kinase 3 (CDK3)
|
|
29.000 (58/200) |
2.53E-16 |
Salt-inducible kinase 1 (SIK1)
|
|
29.167 (63/216) |
3.37E-16 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
29.167 (63/216) |
3.40E-16 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
27.519 (71/258) |
3.45E-16 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
28.906 (74/256) |
3.50E-16 |
Cyclin-dependent kinase 5 (CDK5)
|
|
27.962 (59/211) |
5.39E-16 |
Salt-inducible kinase 2 (SIK2)
|
|
30.049 (61/203) |
6.55E-16 |
ERK activator kinase 5 (MAP2K5)
|
|
29.151 (79/271) |
7.61E-16 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
26.316 (75/285) |
8.26E-16 |
Cyclin-dependent kinase 2 (CDK2)
|
|
28.500 (57/200) |
8.53E-16 |
Cyclin-dependent kinase 15 (CDK15)
|
|
29.386 (67/228) |
1.18E-15 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.889 (65/225) |
1.21E-15 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
29.915 (70/234) |
1.45E-15 |
Protein kinase C theta (PRKCQ)
|
|
26.606 (58/218) |
1.50E-15 |
NIMA-related kinase 7 (NEK7)
|
|
24.823 (70/282) |
1.51E-15 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
28.571 (72/252) |
1.53E-15 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
28.636 (63/220) |
1.83E-15 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
27.509 (74/269) |
2.16E-15 |
SIK family kinase 3 (SIK3)
|
|
29.596 (66/223) |
2.23E-15 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
28.700 (64/223) |
2.37E-15 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
25.322 (59/233) |
3.49E-15 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
27.477 (61/222) |
5.90E-15 |
Serine/threonine-protein kinase NLK (NLK)
|
|
28.000 (56/200) |
6.38E-15 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
24.609 (63/256) |
7.10E-15 |
Serine/threonine-protein kinase MAK (MAK)
|
|
30.102 (59/196) |
8.04E-15 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
27.092 (68/251) |
1.07E-14 |
MAP kinase p38 (MAPK12)
|
|
31.356 (74/236) |
1.13E-14 |
NIMA-related kinase 1 (NEK1)
|
|
25.385 (66/260) |
1.72E-14 |
ERK activator kinase 2 (MEK2)
|
|
32.544 (55/169) |
1.74E-14 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
30.594 (67/219) |
1.81E-14 |
Stress-activated protein kinase 2b (p38 beta)
|
|
27.984 (68/243) |
2.07E-14 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
28.899 (63/218) |
2.29E-14 |
MST-1 protein kinase (STK4)
|
|
25.628 (51/199) |
2.53E-14 |
Cyclin-dependent kinase 14 (CDK14)
|
|
27.442 (59/215) |
2.57E-14 |
Cyclin-dependent kinase 9 (CDK9)
|
|
26.217 (70/267) |
3.08E-14 |
Myosin light kinase (MYLK)
|
|
29.817 (65/218) |
3.14E-14 |
NIMA-related kinase 6 (NEK6)
|
|
24.364 (67/275) |
3.55E-14 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
26.047 (56/215) |
3.59E-14 |
Protein kinase C alpha (PRKCA)
|
|
25.145 (87/346) |
3.72E-14 |
Protein kinase C delta (PRKCD)
|
|
26.364 (58/220) |
3.97E-14 |
Polo-like kinase 1 (PLK1)
|
|
27.132 (70/258) |
4.31E-14 |
Serine/threonine-protein kinase 3 (STK3)
|
|
27.179 (53/195) |
4.51E-14 |
ERK activator kinase 1 (MEK1)
|
|
29.612 (61/206) |
4.78E-14 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
24.623 (49/199) |
5.17E-14 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
26.087 (66/253) |
5.33E-14 |
TGF-beta receptor type I (TGFBR1)
|
|
26.549 (60/226) |
5.50E-14 |
Activin receptor type IB (ACVR1B)
|
|
29.747 (47/158) |
5.83E-14 |
Checkpoint kinase-1 (CHK1)
|
|
30.732 (63/205) |
5.93E-14 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
25.581 (66/258) |
6.10E-14 |
Cyclin-dependent kinase 1 (CDK1)
|
|
26.961 (55/204) |
6.15E-14 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
27.315 (59/216) |
6.53E-14 |
Misshapen-like kinase 1 (MINK1)
|
|
24.623 (49/199) |
6.96E-14 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
25.984 (66/254) |
7.67E-14 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
26.768 (53/198) |
8.05E-14 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
26.556 (64/241) |
1.21E-13 |
Cyclin-dependent kinase 16 (CDK16)
|
|
27.600 (69/250) |
1.38E-13 |
TAO kinase 1 (TAOK1)
|
|
30.000 (66/220) |
1.52E-13 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
28.846 (60/208) |
1.93E-13 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
23.810 (60/252) |
3.44E-13 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
26.230 (64/244) |
4.10E-13 |
Myosin-IIIa (MYO3A)
|
|
27.315 (59/216) |
4.22E-13 |
Serine/threonine-protein kinase 33 (STK33)
|
|
25.279 (68/269) |
4.25E-13 |
MEK kinase kinase 4 (MAP4K4)
|
|
24.623 (49/199) |
4.28E-13 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
29.412 (60/204) |
4.80E-13 |
Protein kinase C epsilon (PRKCE)
|
|
27.358 (58/212) |
5.18E-13 |
Protein kinase C beta (PRKCB)
|
|
26.887 (57/212) |
5.28E-13 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
24.473 (58/237) |
5.92E-13 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
26.812 (74/276) |
6.14E-13 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
25.676 (57/222) |
7.47E-13 |
TAO kinase 3 (TAOK3)
|
|
29.817 (65/218) |
7.57E-13 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
26.106 (59/226) |
8.99E-13 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
28.378 (63/222) |
1.03E-12 |
Protein kinase G1 (PRKG1)
|
|
27.935 (69/247) |
1.23E-12 |
PAK-2 protein kinase (PAK2)
|
|
26.214 (54/206) |
1.26E-12 |
NIMA-related kinase 2 (NEK2)
|
|
25.000 (63/252) |
1.28E-12 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
27.317 (56/205) |
1.28E-12 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
28.251 (63/223) |
1.30E-12 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
27.875 (80/287) |
1.34E-12 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
26.316 (60/228) |
1.53E-12 |
MEK kinase kinase 1 (MAP4K1)
|
|
30.348 (61/201) |
1.58E-12 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
26.337 (64/243) |
1.84E-12 |
Testis-specific serine kinase 2 (TSSK2)
|
|
22.182 (61/275) |
1.91E-12 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
24.280 (59/243) |
1.96E-12 |
Cyclin-dependent kinase 17 (CDK17)
|
|
27.536 (57/207) |
1.96E-12 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
23.827 (66/277) |
2.32E-12 |
Casein kinase I alpha (CSNK1A1)
|
|
25.180 (70/278) |
2.51E-12 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
32.500 (65/200) |
2.52E-12 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
28.646 (55/192) |
2.60E-12 |
ERK activator kinase 7 (MAP2K7)
|
|
27.341 (73/267) |
2.85E-12 |
Death-associated protein kinase 1 (DAPK1)
|
|
27.326 (47/172) |
3.82E-12 |
Aurora kinase C (AURKC)
|
|
24.715 (65/263) |
3.85E-12 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
28.571 (56/196) |
4.05E-12 |
Cyclin-dependent kinase 18 (CDK18)
|
|
26.887 (57/212) |
4.66E-12 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
28.319 (64/226) |
5.19E-12 |
Casein kinase I isoform alpha-like (CSNK1A1L)
|
|
25.180 (70/278) |
6.09E-12 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
23.140 (56/242) |
6.22E-12 |
Cyclin-dependent kinase 10 (CDK10)
|
|
28.505 (61/214) |
7.32E-12 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
29.703 (60/202) |
8.41E-12 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
23.723 (65/274) |
9.28E-12 |
Protein kinase C gamma (PRKCG)
|
|
25.778 (58/225) |
1.10E-11 |
PAK-4 protein kinase (PAK4)
|
|
25.758 (51/198) |
1.12E-11 |
Casein kinase I delta (CSNK1D)
|
|
25.641 (70/273) |
1.15E-11 |
Fused homolog (STK36)
|
|
26.842 (51/190) |
1.17E-11 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
24.453 (67/274) |
1.21E-11 |
Death-associated protein kinase 3 (DAPK3)
|
|
24.424 (53/217) |
1.40E-11 |
Myosin light chain kinase 3 (MYLK3)
|
|
29.327 (61/208) |
1.41E-11 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
26.104 (65/249) |
1.41E-11 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
31.280 (66/211) |
1.50E-11 |
PAK-1 protein kinase (PAK1)
|
|
25.758 (51/198) |
1.76E-11 |
Cyclin-dependent kinase 20 (CDK20)
|
|
28.436 (60/211) |
1.84E-11 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
23.554 (57/242) |
1.85E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
23.478 (54/230) |
2.02E-11 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
26.415 (70/265) |
2.05E-11 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
29.293 (58/198) |
2.69E-11 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
25.962 (54/208) |
3.09E-11 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
26.754 (61/228) |
3.82E-11 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
30.508 (54/177) |
4.31E-11 |
MEK kinase kinase 3 (MAP4K3)
|
|
28.283 (56/198) |
4.63E-11 |
Protein kinase C eta type (PRKCH)
|
|
26.168 (56/214) |
5.15E-11 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
26.108 (53/203) |
5.21E-11 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
27.381 (46/168) |
5.33E-11 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
24.793 (60/242) |
5.80E-11 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
27.237 (70/257) |
5.93E-11 |
Cytoplasmic DRAK1 (STK17A)
|
|
25.571 (56/219) |
6.47E-11 |
Serine/threonine-protein kinase cot (COT)
|
|
23.967 (58/242) |
7.20E-11 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
25.225 (56/222) |
9.35E-11 |
Protein kinase G2 (PRKG2)
|
|
25.926 (63/243) |
9.75E-11 |
Casein kinase I epsilon (CSNK1E)
|
|
25.641 (70/273) |
1.02E-10 |
Aurora kinase A (AURKA)
|
|
25.472 (54/212) |
1.04E-10 |
Yet another novel kinase 2 (STK32B)
|
|
26.852 (58/216) |
1.12E-10 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
27.642 (34/123) |
1.19E-10 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
26.842 (51/190) |
1.22E-10 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
25.225 (56/222) |
1.22E-10 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
24.324 (54/222) |
1.35E-10 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
24.171 (51/211) |
1.70E-10 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
24.891 (57/229) |
1.98E-10 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
24.904 (65/261) |
2.00E-10 |
Death-associated protein kinase 2 (DAPK2)
|
|
25.581 (44/172) |
2.03E-10 |
Protein kinase N2 (PKN2)
|
|
27.236 (67/246) |
2.08E-10 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
26.106 (59/226) |
2.10E-10 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
24.873 (49/197) |
2.21E-10 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
26.554 (47/177) |
2.25E-10 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
24.060 (64/266) |
2.41E-10 |
Cyclin-dependent kinase 6 (CDK6)
|
|
26.866 (54/201) |
2.43E-10 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
25.561 (57/223) |
2.49E-10 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
24.171 (51/211) |
2.53E-10 |
Rho-associated protein kinase 1 (ROCK1)
|
|
26.180 (61/233) |
2.98E-10 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.154 (51/195) |
3.21E-10 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
27.638 (55/199) |
3.38E-10 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
24.706 (63/255) |
3.39E-10 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
28.431 (58/204) |
3.51E-10 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
26.941 (59/219) |
3.84E-10 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
26.941 (59/219) |
4.57E-10 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
28.302 (60/212) |
4.60E-10 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
25.725 (71/276) |
4.95E-10 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
26.407 (61/231) |
5.93E-10 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
25.234 (54/214) |
6.02E-10 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
26.180 (61/233) |
6.49E-10 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
27.090 (81/299) |
7.02E-10 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
25.943 (55/212) |
7.80E-10 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
24.710 (64/259) |
7.85E-10 |
MEK kinase kinase 2 (MAP4K2)
|
|
25.980 (53/204) |
8.32E-10 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
25.090 (70/279) |
9.56E-10 |
Rho-associated protein kinase 2 (ROCK2)
|
|
27.670 (57/206) |
9.92E-10 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
24.453 (67/274) |
9.97E-10 |
Doublecortin-like kinase 1 (DCLK1)
|
|
25.333 (57/225) |
1.01E-09 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
26.941 (59/219) |
1.12E-09 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
29.560 (47/159) |
1.12E-09 |
Serine/threonine-protein kinase 10 (STK10)
|
|
26.761 (57/213) |
1.13E-09 |
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
27.064 (59/218) |
1.21E-09 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
26.848 (69/257) |
1.28E-09 |
STE20-related kinase adapter protein beta (STRADB)
|
|
24.576 (58/236) |
1.41E-09 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
25.610 (63/246) |
1.57E-09 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
23.200 (58/250) |
1.64E-09 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
27.027 (60/222) |
1.87E-09 |
Cyclin-dependent kinase 7 (CDK7)
|
|
25.792 (57/221) |
1.93E-09 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
27.742 (43/155) |
2.04E-09 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
26.106 (59/226) |
2.08E-09 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
24.873 (49/197) |
2.49E-09 |
Cyclin-dependent kinase 8 (CDK8)
|
|
25.118 (53/211) |
3.01E-09 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
23.106 (61/264) |
3.03E-09 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
25.263 (48/190) |
3.05E-09 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
24.597 (61/248) |
3.35E-09 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
25.207 (61/242) |
3.67E-09 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
28.283 (56/198) |
3.68E-09 |
Cyclin-dependent kinase 19 (CDK19)
|
|
25.481 (53/208) |
3.83E-09 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
25.472 (54/212) |
3.98E-09 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
24.324 (54/222) |
4.28E-09 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
29.082 (57/196) |
4.59E-09 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
29.050 (52/179) |
5.86E-09 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
22.383 (62/277) |
6.21E-09 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
25.271 (70/277) |
6.25E-09 |
Nik-related protein kinase (NRK)
|
|
21.951 (54/246) |
6.56E-09 |
Citron Rho-interacting kinase (CIT)
|
|
28.019 (58/207) |
6.68E-09 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
25.698 (46/179) |
6.90E-09 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
34.343 (34/99) |
6.97E-09 |
Membrane-associated kinase (PKMYT1)
|
|
26.378 (67/254) |
7.35E-09 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
25.359 (53/209) |
7.49E-09 |
Protein kinase D (PRKD1)
|
|
25.263 (48/190) |
7.61E-09 |
Myosin-IIIb (MYO3B)
|
|
26.201 (60/229) |
8.10E-09 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
25.676 (57/222) |
8.61E-09 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
25.253 (50/198) |
9.43E-09 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
36.538 (38/104) |
9.78E-09 |
Doublecortin-like kinase 3 (DCLK3)
|
|
25.668 (48/187) |
1.08E-08 |
Titin (TTN)
|
25.000 (53/212) |
1.31E-08 |
Doublecortin-like kinase 2 (DCLK2)
|
|
22.967 (48/209) |
1.35E-08 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
25.258 (49/194) |
1.50E-08 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
24.354 (66/271) |
1.77E-08 |
NF-kappa-B-activating kinase (TBK1)
|
|
26.293 (61/232) |
1.89E-08 |
Aurora kinase B (AURKB)
|
|
24.211 (69/285) |
2.00E-08 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.244 (58/221) |
2.26E-08 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
27.907 (60/215) |
2.54E-08 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
21.875 (56/256) |
2.85E-08 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
25.767 (42/163) |
3.33E-08 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
23.438 (45/192) |
3.65E-08 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
25.792 (57/221) |
3.98E-08 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
28.082 (41/146) |
4.01E-08 |
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
24.312 (53/218) |
4.09E-08 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
25.806 (64/248) |
4.95E-08 |
Protein kinase N1 (PKN1)
|
|
26.437 (69/261) |
8.57E-08 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
25.446 (57/224) |
1.67E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
29.878 (49/164) |
1.69E-07 |
Obscurin (OBSCN)
|
|
27.211 (40/147) |
1.81E-07 |
Activin receptor type IIB (ACVR2B)
|
|
25.904 (43/166) |
2.00E-07 |
PIM-3 protein kinase (PIM3)
|
|
26.846 (40/149) |
2.05E-07 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
23.478 (54/230) |
2.14E-07 |
Protein kinase C iota (PRKCI)
|
|
22.179 (57/257) |
2.35E-07 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
24.876 (50/201) |
2.38E-07 |
CDC-like kinase 1 (CLK1)
|
|
27.586 (64/232) |
2.61E-07 |
Rhodopsin kinase GRK7 (GRK7)
|
|
23.318 (52/223) |
2.99E-07 |
Cyclin-dependent kinase 4 (CDK4)
|
|
31.633 (31/98) |
3.11E-07 |
TGF-beta-stimulated factor 1 (STK16)
|
|
23.273 (64/275) |
3.60E-07 |
CaM-kinase IV kinase (CAMKK1)
|
|
26.087 (42/161) |
3.90E-07 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
21.397 (49/229) |
4.46E-07 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
25.131 (48/191) |
7.12E-07 |
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
25.581 (66/258) |
8.31E-07 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
25.366 (52/205) |
8.90E-07 |
Rho guanine nucleotide exchange factor 7 (ARHGEF7)
|
|
30.909 (34/110) |
9.43E-07 |
Activin receptor type IIA (ACVR2A)
|
|
26.214 (54/206) |
9.99E-07 |
Bone morphogenetic protein receptor (BMPR2)
|
|
24.696 (61/247) |
1.07E-06 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
24.080 (72/299) |
1.10E-06 |
Tau-tubulin kinase 2 (TTBK2)
|
|
19.366 (55/284) |
1.15E-06 |
Protein kinase C zeta (PRKCZ)
|
|
21.656 (68/314) |
1.36E-06 |
BMP-2-inducible protein kinase (BMP2K)
|
|
25.571 (56/219) |
1.38E-06 |
Cyclin-G-associated kinase (GAK)
|
|
26.457 (59/223) |
1.43E-06 |
Sugen kinase 110 (SBK3)
|
|
29.221 (45/154) |
1.67E-06 |
Serine/threonine-protein kinase 35 (STK35)
|
|
27.039 (63/233) |
1.84E-06 |
Casein kinase I gamma-1 (CSNK1G1)
|
|
23.247 (63/271) |
2.08E-06 |
Casein kinase I gamma-2 (CSNK1G2)
|
|
22.593 (61/270) |
2.18E-06 |
Casein kinase I gamma-3 (CSNK1G3)
|
|
22.305 (60/269) |
2.91E-06 |
Protein kinase N3 (PKN3)
|
|
29.630 (64/216) |
3.71E-06 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
25.794 (65/252) |
4.25E-06 |
Kalirin (KALRN)
|
|
24.312 (53/218) |
4.70E-06 |
SRSF protein kinase 1 (SRPK1)
|
|
29.787 (42/141) |
6.01E-06 |
CDC-like kinase 3 (CLK3)
|
|
25.862 (60/232) |
6.11E-06 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
25.446 (57/224) |
6.49E-06 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
26.178 (50/191) |
7.45E-06 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
24.219 (31/128) |
9.79E-06 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
22.059 (45/204) |
1.40E-05 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
29.323 (39/133) |
1.51E-05 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
22.430 (48/214) |
1.70E-05 |
CDC-like kinase 4 (CLK4)
|
|
27.143 (57/210) |
2.07E-05 |
Tau-tubulin kinase (TTBK1)
|
|
21.034 (61/290) |
2.27E-05 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
27.950 (45/161) |
2.59E-05 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
26.708 (43/161) |
2.96E-05 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
28.846 (60/208) |
3.01E-05 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
26.515 (35/132) |
3.98E-05 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
27.950 (45/161) |
4.02E-05 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
25.114 (55/219) |
4.13E-05 |
NDR1 protein kinase (STK38)
|
|
21.429 (60/280) |
4.80E-05 |
NDR2 protein kinase (STK38L)
|
|
20.974 (56/267) |
5.05E-05 |
SRSF protein kinase 3 (SRPK3)
|
|
27.857 (39/140) |
6.11E-05 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
28.251 (63/223) |
6.23E-05 |
PDZ binding kinase (PBK)
|
|
21.951 (63/287) |
6.62E-05 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
23.567 (37/157) |
6.95E-05 |
RIMS-binding protein 2 (RIMBP2)
|
|
24.342 (37/152) |
7.13E-05 |
Myotonin-protein kinase (DMPK)
|
|
27.879 (46/165) |
7.42E-05 |
SRSF protein kinase 2 (SRPK2)
|
|
28.058 (39/139) |
8.26E-05 |
Rho guanine nucleotide exchange factor 6 (ARHGEF6)
|
|
22.099 (40/181) |
9.16E-05 |
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
22.747 (53/233) |
1.12E-04 |
Wee1-like protein kinase (WEE1)
|
|
23.704 (32/135) |
1.17E-04 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
26.977 (58/215) |
1.21E-04 |
CDC-like kinase 2 (CLK2)
|
|
24.138 (56/232) |
1.48E-04 |
Rhodopsin kinase GRK1 (GRK1)
|
|
23.016 (58/252) |
1.72E-04 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
23.396 (62/265) |
1.93E-04 |
LIM and SH3 domain protein 1 (LASP1)
|
|
30.769 (20/65) |
2.22E-04 |
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
23.182 (51/220) |
2.39E-04 |
Abl interactor 2 (ABI2)
|
|
34.615 (18/52) |
2.48E-04 |
Wee1-like protein kinase 2 (WEE2)
|
|
22.963 (31/135) |
3.05E-04 |
Nostrin (NOSTRIN)
|
|
37.662 (29/77) |
3.07E-04 |
Click to Show/Hide the Information of Human Similarity Proteins |